Cardiff Oncology
CRDF
CRDF
83 hedge funds and large institutions have $34.1M invested in Cardiff Oncology in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 90 → 83 (-7)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
Holders
83
Holding in Top 10
–
Calls
$2.19M
Puts
$406K
Top Buyers
| 1 | +$1.19M | |
| 2 | +$760K | |
| 3 | +$564K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$405K |
| 5 |
Two Sigma Advisers
New York
|
+$332K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$416K | |
| 3 | -$333K | |
| 4 |
Millennium Management
New York
|
-$232K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$191K |